Know Labs Announces UBAND™ Calorie Counter Wristband

Download as PDF

Based Upon Invention of Non-Invasive Blood Glucose Measurement

SEATTLE--(BUSINESS WIRE)-- Know Labs, Inc. (OTCQB: KNWN) – a provider of identification, authentication and diagnostic solutions, published an advertisement in the Seattle Times newspaper today announcing its UBAND™ real time wearable calorie counter wrist band. The first 1000 respondents to the ad can get on the list to obtain the UBAND for $99. The Calorie Counter UBAND is built upon the Company’s recent invention that detects blood glucose non-invasively. We expect an automatic calorie counter to be in demand by people who like to keep fit and maintain a healthy lifestyle.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005229/en/

(Graphic: Business Wire)

(Graphic: Business Wire)

About Know Labs, Inc.

Know Labs, Inc. (f/k/a Visualant Incorporated) is a public company whose shares currently trade under the stock symbol “KNWN.” The company’s technology directs structured light or radio waves through a substance or material to capture a unique molecular signature. The Company refers to these signatures as ChromaID™ and Bio-RFID™. ChromaID and Bio-RFID are used to identify, detect or diagnose substance markers or biomarkers that may be invisible to the human eye. ChromaID and Bio-RFID scanner modules can be integrated into a variety of wearable, mobile or bench-top form factors. This patented and patent-pending, award-winning technology makes it possible to effectively conduct analyses that could only previously be performed by invasive and/or large and expensive lab-based tests. UBAND™, ChromaID™ and Bio-RFID™ are trademarks of Know Labs, Inc. For more information on Know Labs, visit the company’s website at www.knowlabs.co.

This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Know Labs, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words may, would, will, expect, estimate, can, believe, potential and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Know Labs, Inc.’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

Know Labs, Inc.
Sonia Barberio, 206-903-1351
hello@knowlabs.co

Source: Know Labs, Inc.

Released August 15, 2018